Switch to:
ISIS Pharmaceuticals Inc (NAS:ISIS)
Additional Paid-In Capital
$1,224.5 Mil (As of Dec. 2014)

ISIS Pharmaceuticals Inc's quarterly additional paid-in capital increased from Jun. 2014 ($1,353.0 Mil) to Sep. 2014 ($1,365.4 Mil) but then declined from Sep. 2014 ($1,365.4 Mil) to Dec. 2014 ($1,224.5 Mil).

ISIS Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2012 ($1,077.2 Mil) to Dec. 2013 ($1,324.8 Mil) but then declined from Dec. 2013 ($1,324.8 Mil) to Dec. 2014 ($1,224.5 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

ISIS Pharmaceuticals Inc Annual Data

AdditionalPaidInCapital 770.3881.0828.0905.7985.61,000.21,013.61,077.21,324.81,224.5

ISIS Pharmaceuticals Inc Quarterly Data

AdditionalPaidInCapital 1,073.71,077.21,091.81,292.71,315.61,324.81,343.91,353.01,365.41,224.5
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial